Literature DB >> 19555996

Total laparoscopic radical hysterectomy for locally advanced cervical carcinoma (stages IIB, IIA and bulky stages IB) after concurrent chemoradiation therapy: surgical morbidity and oncological results.

P E Colombo1, M M Bertrand, M Gutowski, A Mourregot, M Fabbro, B Saint-Aubert, F Quenet, S Gourgou, C Kerr, P Rouanet.   

Abstract

OBJECTIVES: To evaluate the surgical outcome and the oncologic results of total laparoscopic radical hysterectomy (TLRH) after neoadjuvant chemoradiation therapy (CRT) for locally advanced cervical carcinoma.
METHODS: All patients who underwent TLRH after CRT for stages IIB-IIA and bulky IB diseases were reviewed. The control group for this analysis was a cohort of patients treated with abdominal radical hysterectomy (ARH) after CRT for the same stage cancers.
RESULTS: We reviewed 102 patients operated on between 2000 and 2008 (46 TLRH and 56 ARH). Mean age at diagnosis was 44 years, and mean B.M.I was 22.1. There was no difference in tumor characteristics between the two groups. Seven patients in the laparoscopic group required conversion to laparotomy (15%). Mean estimated blood loss (200 vs. 400 mL, p<0.01) and the median duration of hospital stay (5 vs. 8 days, p<0.01) were significantly lower in the laparoscopic group. Morbidity rates and urinary complications were reduced in the laparoscopic group (p=0.04). Local recurrence rates, disease-free and overall survival were comparable in the two groups. Best survival was observed for patients with pathological complete response or microscopic residual disease compared to patients with macroscopic residues (p<0.01).
CONCLUSIONS: Radical hysterectomy after CRT is known to be difficult with significant morbidity rates and remains controversial in comparison to exclusive CRT. TLRH after preoperative CRT is feasible for patients with locally advanced cervical cancer in 85% of the cases. For these patients, TLRH compared with ARH was associated with favorable surgical outcome with comparable oncological results.

Entities:  

Mesh:

Year:  2009        PMID: 19555996     DOI: 10.1016/j.ygyno.2009.05.043

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  15 in total

1.  MRI anatomy of parametrial extension to better identify local pathways of disease spread in cervical cancer.

Authors:  Anna Lia Valentini; Benedetta Gui; Maura Miccò; Michela Giuliani; Elena Rodolfino; Valeria Ninivaggi; Marta Iacobucci; Marzia Marino; Maria Antonietta Gambacorta; Antonia Carla Testa; Gian Franco Zannoni; Lorenzo Bonomo
Journal:  Diagn Interv Radiol       Date:  2016 Jul-Aug       Impact factor: 2.630

2.  Patterns of care in patients with cervical cancer 2012: results of a survey among German radiotherapy departments and out-patient health care centers.

Authors:  S Marnitz; C Köhler; A Rauer; A Schneider; V Budach; A Tsunoda; M Mangler
Journal:  Strahlenther Onkol       Date:  2013-07-27       Impact factor: 3.621

3.  Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer.

Authors:  Cyril Touboul; Catherine Uzan; Audrey Mauguen; Sebastien Gouy; Annie Rey; Patricia Pautier; Catherine Lhommé; Pierre Duvillard; Christine Haie-Meder; Philippe Morice
Journal:  Oncologist       Date:  2010-03-23

4.  Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer.

Authors:  Philippe Morice; Philippe Rouanet; Annie Rey; Pascale Romestaing; Gilles Houvenaeghel; Jean Charles Boulanger; Jean Leveque; Didier Cowen; Patrice Mathevet; Jean Pierre Malhaire; Guillaume Magnin; Eric Fondrinier; Jocelyne Berille; Christine Haie-Meder
Journal:  Oncologist       Date:  2012-01-10

Review 5.  Adenocarcinoma of the cervix: should we treat it differently?

Authors:  Ned L Williams; Theresa L Werner; Elke A Jarboe; David K Gaffney
Journal:  Curr Oncol Rep       Date:  2015-04       Impact factor: 5.075

Review 6.  Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.

Authors:  Fani Kokka; Andrew Bryant; Adeola Olaitan; Elly Brockbank; Melanie Powell; David Oram
Journal:  Cochrane Database Syst Rev       Date:  2022-08-22

7.  Aspects of Therapy for Cervical Cancer in Germany 2012 - Results from a Survey of German Gynaecological Hospitals.

Authors:  M Mangler; N Zech; A Schneider; C Köhler; S Marnitz
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-03       Impact factor: 2.915

8.  Pathway profiling and rational trial design for studies in advanced stage cervical carcinoma: a review and a perspective.

Authors:  Susy M E Scholl; Gemma Kenter; Christian Kurzeder; Philippe Beuzeboc
Journal:  ISRN Oncol       Date:  2011-07-06

9.  Various types of total laparoscopic nerve-sparing radical hysterectomies and their effects on bladder function.

Authors:  Hiroyuki Kanao; Kazuko Fujiwara; Keiko Ebisawa; Tomonori Hada; Yoshiaki Ota; Masaaki Andou
Journal:  J Gynecol Oncol       Date:  2014-07-03       Impact factor: 4.401

10.  Clinical outcome observation of preoperative concurrent chemoradiotherapy/radiotherapy alone in 174 Chinese patients with local advanced cervical carcinoma.

Authors:  Li-Chun Wei; Ning Wang; Mei Shi; Jun-Yue Liu; Jian-Ping Li; Ying Zhang; Yan-Hong Huang; Xia Li; Yan Chen
Journal:  Onco Targets Ther       Date:  2013-02-07       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.